Clinical Trial Update: Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-on study of lomitapide in patients with homozygous familial hypercholesterolemia. Results from the completed study were posted in May 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Lomitapide (lomitapide)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Familial Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2018-05-11